1 Warnberg, J & Marcos, A (2008) Low-grade inflammation and the metabolic syndrome in children and adolescents. Curr Opin Lipidol 19, 11–15.
2 Calle, EE & Kaaks, R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4, 579–591.
3 Pan, SY, Johnson, KC, Ugnat, AM, et al. (2004) Association of obesity and cancer risk in Canada. Am J Epidemiol 159, 259–268.
4 Ridker, PM, Buring, JE, Shih, J, et al. (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98, 731–733.
5 Ridker, PM, Hennekens, CH, Buring, JE, et al. (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342, 836–843.
6 Duncan, BB, Schmidt, MI, Pankow, JS, et al. (2003) Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52, 1799–1805.
7 Falagas, ME & Kompoti, M (2006) Obesity and infection. Lancet Infect Dis 6, 438–446.
8 Weber, DJ, Rutala, WA, et al. (1985) Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. J Am Med Assoc 254, 3187–3189.
9 Simo, MJ, Gaztambide, GM, Fernandez, MP, et al. (1996) Hepatitis B vaccine immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination. Vaccine 14, 103–106.
10 Eliakim, A, Schwindt, C, Zaldivar, F, et al. (2006) Reduced tetanus antibody titers in overweight children. Autoimmunity 39, 137–141.
11 Tanaka, S, Inoue, S, Isoda, F, et al. (1993) Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord 17, 631–636.
12 Tanaka, S, Isoda, F, Ishihara, Y, et al. (2001) T lymphopaenia in relation to body mass index and TNF-alpha in human obesity: adequate weight reduction can be corrective. Clin Endocrinol (Oxf) 54, 347–354.
13 Russell, JC, Koeslag, DG, Amy, RM, et al. (1989) Plasma lipid secretion and clearance in hyperlipidemic JCR:LA-corpulent rats. Arteriosclerosis 9, 869–876.
14 Russell, JC, Graham, S & Hameed, M (1994) Abnormal insulin and glucose metabolism in the JCR:LA-corpulent rat. Metabolism 43, 538–543.
15 Dolphin, PJ, Stewart, B, Amy, RM, et al. (1987) Serum lipids and lipoproteins in the atherosclerosis prone LA/N corpulent rat. Biochim Biophys Acta 919, 140–148.
16 Calder, PC & Grimble, RF (2002) Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr Suppl 3, 56, S14–S19.
17 Calder, PC (2006) n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83, 1505S–1519S.
18 Aguilera, AA, Diaz, GH, Barcelata, ML, et al. (2004) Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor-alpha in rats with sucrose-induced metabolic syndrome. J Nutr Biochem 15, 350–357.
19 Guermouche, B, Yessoufou, A, Soulimane, N, et al. (2004) n-3 fatty acids modulate T-cell calcium signaling in obese macrosomic rats. Obes Res 12, 1744–1753.
20 Khan, NA, Yessoufou, A, Kim, M, et al. (2006) n-3 fatty acids modulate Th1 and Th2 dichotomy in diabetic pregnancy and macrosomia. J Autoimmun 26, 268–277.
21 Chan, DC, Watts, GF, Barrett, PH, et al. (2002) Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity. Clin Chem 48, 877–883.
22 Jellema, A, Plat, J & Mensink, RP (2004) Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest 34, 766–773.
23 Plat, J, Jellema, A, Ramakers, J, et al. (2007) Weight loss, but not fish oil consumption, improves fasting and postprandial serum lipids, markers of endothelial function, and inflammatory signatures in moderately obese men. J Nutr 137, 2635–2640.
24 Browning, LM, Krebs, JD, Moore, CS, et al. (2007) The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 9, 70–80.
25 Brown, DA & London, E (1998) Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14, 111–136.
26 Dykstra, M, Cherukuri, A, Sohn, HW, et al. (2003) Location is everything: lipid rafts and immune cell signaling. Annu Rev Immunol 21, 457–481.
27 Shaikh, SR & Edidin, MA (2006) Membranes are not just rafts. Chem Phys Lipids 144, 1–3.
28 Dolphin, PJ (1981) Serum and hepatic nascent lipoproteins in normal and hypercholesterolemic rats. J Lipid Res 22, 971–989.
29 Reimer, RA & Russell, JC (2008) Glucose tolerance, lipids, and GLP-1 secretion in JCR:LA-cp rats fed a high protein fiber diet. Obesity (Silver Spring) 16, 40–46.
30 Field, CJ, Wu, G, Metroz-Dayer, MD, et al. (1990) Lactate production is the major metabolic fate of glucose in splenocytes and is altered in spontaneously diabetic BB rats. Biochem J 272, 445–452.
31 Ruth, MR, Taylor, CG, Zahradka, P, et al. (2008) Abnormal immune responses in fa/fa Zucker rats and effects of feeding conjugated linoleic acid. Obesity (Silver Spring) 16, 1770–1779.
32 Field, CJ, Thomson, CA, Van Aerde, JE, et al. (2000) Lower proportion of CD45R0+ cells and deficient interleukin-10 production by formula-fed infants, compared with human-fed, is corrected with supplementation of long-chain polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr 31, 291–299.
33 Schley, PD, Brindley, DN & Field, CJ (2007) (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J Nutr 137, 548–553.
34 Field, CJ, Ryan, EA, Thomson, AB, et al. (1988) Dietary fat and the diabetic state alter insulin binding and the fatty acyl composition of the adipocyte plasma membrane. Biochem J 253, 417–424.
35 Layne, KS, Goh, YK, Jumpsen, JA, et al. (1996) Normal subjects consuming physiological levels of 18:3(n-3) and 20:5(n-3) from flaxseed or fish oils have characteristic differences in plasma lipid and lipoprotein fatty acid levels. J Nutr 126, 2130–2140.
36 Cruz-Hernandez, C, Deng, Z, Zhou, J, et al. (2004) Methods for analysis of conjugated linoleic acids and trans-18:1 isomers in dairy fats by using a combination of gas chromatography, silver-ion thin-layer chromatography/gas chromatography, and silver-ion liquid chromatography. J AOAC Int 87, 545–562.
37 Busso, N, So, A, Chobaz-Peclat, V, et al. (2002) Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 168, 875–882.
38 Katagiri, K, Arakawa, S, Kurahashi, R, et al. (2007) Impaired contact hypersensitivity in diet-induced obese mice. J Dermatol Sci 46, 117–126.
39 Lamas, O, Martinez, JA & Marti, A (2004) Decreased splenic mRNA expression levels of TNF-alpha and IL-6 in diet-induced obese animals. J Physiol Biochem 60, 279–283.
40 Fontana, L, Eagon, JC, Colonna, M, et al. (2007) Impaired mononuclear cell immune function in extreme obesity is corrected by weight loss. Rejuvenation Res 10, 41–46.
41 Mito, N, Hosoda, T, Kato, C, et al. (2000) Change of cytokine balance in diet-induced obese mice. Metabolism 49, 1295–1300.
42 Lamas, O, Martinez, JA & Marti, AT-helper (2002) lymphopenia and decreased mitogenic response in cafeteria diet-induced obese rats. Nutr Res 22, 497–506.
43 Moriguchi, S, Kato, M, Sakai, K, et al. (1998) Exercise training restores decreased cellular immune functions in obese Zucker rats. J Appl Physiol 84, 311–317.
44 Tanaka, S, Isoda, F, Yamakawa, T, et al. (1998) T lymphopenia in genetically obese rats. Clin Immunol Immunopathol 86, 219–225.
45 Lamas, O, Martinez, JA & Marti, A (2003) Effects of a beta3-adrenergic agonist on the immune response in diet-induced (cafeteria) obese animals. J Physiol Biochem 59, 183–191.
46 Mito, N, Kaburagi, T, Yoshino, H, et al. (2006) Oral-tolerance induction in diet-induced obese mice. Life Sci 79, 1056–1061.
47 Pacifico, L, Di, RL, Anania, C, et al. (2006) Increased T-helper interferon-gamma-secreting cells in obese children. Eur J Endocrinol 154, 691–697.
48 Svec, P, Vasarhelyi, B, Paszthy, B, et al. (2007) Do regulatory T cells contribute to Th1 skewness in obesity? Exp Clin Endocrinol Diabetes 115, 439–443.
49 Russell, JC & Amy, RM (1986) Myocardial and vascular lesions in the LA/N-corpulent rat. Can J Physiol Pharmacol 64, 1272–1280.
50 Russell, JC & Amy, RM (1986) Early atherosclerotic lesions in a susceptible rat model. The LA/N-corpulent rat. Atherosclerosis 60, 119–129.
51 Loffreda, S, Yang, SQ, Lin, HZ, et al. (1998) Leptin regulates proinflammatory immune responses. FASEB J 12, 57–65.
52 Martin-Romero, C, Santos-Alvarez, J, Goberna, R, et al. (2000) Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 199, 15–24.
53 Lord, GM, Matarese, G, Howard, JK, et al. (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394, 897–901.
54 Mattioli, B, Straface, E, Quaranta, MG, et al. (2005) Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J Immunol 174, 6820–6828.
55 Matarese, G, Di, GA, Sanna, V, et al. (2001) Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 166, 5909–5916.
56 Siegmund, B, Sennello, JA, Jones-Carson, J, et al. (2004) Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice. Gut 53, 965–972.
57 Papathanassoglou, E, El-Haschimi, K, Li, XC, et al. (2006) Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. J Immunol 176, 7745–7752.
58 Wu-Peng, XS, Chua, SC Jr, Okada, N, et al. (1997) Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes 46, 513–518.
59 Matarese, G, Moschos, S & Mantzoros, CS (2005) Leptin in immunology. J Immunol 174, 3137–3142.
60 Jolly, CA, Jiang, YH, Chapkin, RS, et al. (1997) Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide. J Nutr 127, 37–43.
61 Wallace, FA, Miles, EA, Evans, C, et al. (2001) Dietary fatty acids influence the production of Th1- but not Th2-type cytokines. J Leukoc Biol 69, 449–457.
62 Arrington, JL, McMurray, DN, Switzer, KC, et al. (2001) Docosahexaenoic acid suppresses function of the CD28 costimulatory membrane receptor in primary murine and Jurkat T cells. J Nutr 131, 1147–1153.
63 Fan, YY, Ly, LH, Barhoumi, R, et al. (2004) Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production. J Immunol 173, 6151–6160.
64 Jeffery, NM, Cortina, M, Newsholme, EA, et al. (1997) Effects of variations in the proportions of saturated, monounsaturated and polyunsaturated fatty acids in the rat diet on spleen lymphocyte functions. Br J Nutr 77, 805–823.
65 Yaqoob, P, Newsholme, EA & Calder, PC (1994) The effect of dietary lipid manipulation on rat lymphocyte subsets and proliferation. Immunology 82, 603–610.
66 Phinney, SD, Tang, AB, Thurmond, DC, et al. (1993) Abnormal polyunsaturated lipid metabolism in the obese Zucker rat, with partial metabolic correction by gamma-linolenic acid administration. Metabolism 42, 1127–1140.
67 Guesnet, P, Bourre, JM, Guerre-Millo, M, et al. (1990) Tissue phospholipid fatty acid composition in genetically lean (Fa/-) or obese (fa/fa) Zucker female rats on the same diet. Lipids 25, 517–522.
68 Ma, DW, Seo, J, Switzer, KC, et al. (2004) and membrane microdomains: a new frontier in bioactive lipid research. J Nutr Biochem 15, 700–706.
69 Buatois, V, Baillet, M, Becart, S, et al. (2003) MHC class II-peptide complexes in dendritic cell lipid microdomains initiate the CD4 Th1 phenotype. J Immunol 171, 5812–5819.
70 Zilber, MT, Setterblad, N, Vasselon, T, et al. (2005) MHC class II/CD38/CD9: a lipid-raft-dependent signaling complex in human monocytes. Blood 106, 3074–3081.
71 Huby, RD, Dearman, RJ & Kimber, I (1999) Intracellular phosphotyrosine induction by major histocompatibility complex class II requires co-aggregation with membrane rafts. J Biol Chem 274, 22591–22596.
72 Anderson, HA, Hiltbold, EM & Roche, PA (2000) Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat Immunol 1, 156–162.
73 Sanderson, P, MacPherson, GG, Jenkins, CH, et al. (1997) Dietary fish oil diminishes the antigen presentation activity of rat dendritic cells. J Leukoc Biol 62, 771–777.